Akèy › Ajitasyon psikomotè
Etid klinik pou Ajitasyon psikomotè ap rekrite nan Etazini
8 etid pou Ajitasyon psikomotè ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
- Arizona3 etid
- Florid5 etid
- Georgia3 etid
- Kalifòni4 etid
- Massachusetts3 etid
- New Jersey3 etid
- New York4 etid
- North Carolina3 etid
- Ohio3 etid
- Texas3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Neurosteer Bedside Monitoring System
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06718764A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 28, 2026 · NCT06937229A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07011745Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Sep 16, 2026 · NCT06052254Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 1, 2026 · NCT06808984Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients
Ap rekriteVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Jun 22, 2026 · NCT07649876Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou May 28, 2026 · NCT06781333Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
Ap rekriteFaz 2
Laj 50 a 90 · Tout sèks · Mizajou Feb 16, 2023 · NCT04436081Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.